Twinbeech Capital LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Twinbeech Capital LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $4.27 Million - $7.49 Million	-51,311 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $5.65 Million - $7.33 Million	51,311 New	51,311 $6.08 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $812,383 - $1.3 Million	-12,350 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $94,823 - $135,790	1,480 Added 13.62%	12,350 $844,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $707,310 - $1.07 Million	10,870 New	10,870 $932,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.